מדיקינט MR כמוסות בשחרור מושהה 20 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג ישראל - עברית - Ministry of Health

מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מדיקינט MR כמוסות בשחרור מושהה 40 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 40 מ"ג

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

אסנטה 5 ישראל - עברית - Ministry of Health

אסנטה 5

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

אסנטה 10 ישראל - עברית - Ministry of Health

אסנטה 10

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

דונפזיל טבע   5 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 5 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

דונפזיל טבע   5 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 5 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

דונפזיל טבע   10 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 10 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

אקסלון   1.5 מג ישראל - עברית - Ministry of Health

אקסלון 1.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.